The global exoskeleton market size was USD 426.02 million in 2023, calculated at USD 496.87 million in 2024 and is expected to be worth around USD 2,313.89 million by 2034. The market is slated to expand at 16.63% CAGR from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Exoskeleton Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Exoskeleton Market Revenue and Volume, by Mobility, 2024-2034
8.1.1. Mobile
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Fixed/Stationary
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Exoskeleton Market Revenue and Volume, by Technology, 2024-2034
9.1.1. Powered
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Non-powered
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Exoskeleton Market Revenue and Volume, by Extremity, 2024-2034
10.1.1. Upper Body
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Lower Body
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Full Body
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
11.1. Exoskeleton Market Revenue and Volume, by Structure, 2024-2034
11.1.1. Rigid Exoskeleton
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Soft Exoskeleton
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
12.1. Exoskeleton Market Revenue and Volume, by End-use, 2024-2034
12.1.1. Industry
12.1.1.1. Market Revenue and Volume Forecast (2021-2034)
12.1.2. Military
12.1.2.1. Market Revenue and Volume Forecast (2021-2034)
12.1.3. Healthcare
12.1.3.1. Market Revenue and Volume Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.1.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.1.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.1.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.1.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.1.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.1.6.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.1.6.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.1.6.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.1.7.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.1.7.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.1.7.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.1.7.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.2.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.2.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.2.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.2.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.2.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.2.6.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.2.7. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.2.8. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.2.9.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.2.9.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.2.10. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.2.11. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.2.12.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.2.12.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.2.12.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.2.13. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.2.14.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.2.14.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.2.14.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.2.15. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.3.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.3.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.3.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.3.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.3.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.3.6.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.3.6.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.3.7. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.3.8.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.3.8.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.3.8.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.3.9. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.3.10.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.3.10.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.3.10.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.3.10.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.3.11.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.3.11.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.3.11.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.3.11.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.4.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.4.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.4.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.4.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.4.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.4.6.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.4.6.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.4.7. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.4.8.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.4.8.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.4.8.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.4.9. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.4.10.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.4.10.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.4.10.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.4.10.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.4.11.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.4.11.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.4.11.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.4.11.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.5.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.5.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.5.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.5.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.5.6.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.5.6.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.5.7. Market Revenue and Volume Forecast, by End-use (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Mobility (2021-2034)
13.5.8.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
13.5.8.3. Market Revenue and Volume Forecast, by Extremity (2021-2034)
13.5.8.4. Market Revenue and Volume Forecast, by Structure (2021-2034)
13.5.8.5. Market Revenue and Volume Forecast, by End-use (2021-2034)
14.1. ActiveLink (Panasonic Corporation)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Cyberdyne, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. ReWalk Robotics
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. RB3D
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Rex Bionics Plc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Suit X
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Lockheed Martin Corporation
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Hocoma
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Ekso Bionics
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Sarcos
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client